1. Zhang, Y, Wang, C. 2011. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells. In Oncogene, 30, 3549-62. doi:10.1038/onc.2011.69. https://pubmed.ncbi.nlm.nih.gov/21423212/
2. Borkham-Kamphorst, Erawan, van Roeyen, Claudia R, Van de Leur, Eddy, Floege, Jürgen, Weiskirchen, Ralf. 2011. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. In Journal of cell communication and signaling, 6, 11-25. doi:10.1007/s12079-011-0141-3. https://pubmed.ncbi.nlm.nih.gov/21748432/
3. Abd El Kader, Tarek, Kubota, Satoshi, Janune, Danilo, Kuboki, Takuo, Takigawa, Masaharu. 2012. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family. In Journal of cell communication and signaling, 7, 11-8. doi:10.1007/s12079-012-0180-4. https://pubmed.ncbi.nlm.nih.gov/23065484/
4. Wu, L, Runkle, C, Jin, H-J, Lee, C, Yu, J. 2013. CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor. In Oncogene, 33, 504-13. doi:10.1038/onc.2012.602. https://pubmed.ncbi.nlm.nih.gov/23318417/
5. Kuwahara, Miho, Kadoya, Koichi, Kondo, Sei, Kubota, Satoshi, Hattori, Takako. 2020. CCN3 (NOV) Drives Degradative Changes in Aging Articular Cartilage. In International journal of molecular sciences, 21, . doi:10.3390/ijms21207556. https://pubmed.ncbi.nlm.nih.gov/33066270/